Clinical Trial Update: Efficacy and Safety of RX-10045 Ophthalmic Solution for Ocular Inflammation and Pain in Cataract Surgery [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating efficacy and safety of RX-10045 ophthalmic solution for ocular inflammation and pain after cataract surgery; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cataract
• Ocular Inflammation

Drugs mentioned

• RX-10045 Ophthalmic Solution (RX-10045)

Snippet

Sponsor: A.T. Resolve SARL | Conditions: Inflammation, Pain | Phase 2 | Status: COMPLETED | Results posted: 2019-02-05